Belsomra vs Ambien: Comparing Two Sleep Medications
How Belsomra and Ambien compare, the different ways they work, their effectiveness and side effects, and the differences in dependence and addiction risk.
Clinically reviewed by Dr. Ponlawat Pitsuwan, Physician and Addiction Medicine Specialist, Phuket Island Rehab.
Belsomra (suvorexant) and Ambien (zolpidem) are both prescription medications approved to treat insomnia, but they work in completely different ways. Ambien is a sedative-hypnotic (a Z-drug) that works like benzodiazepines, by enhancing the calming brain chemical GABA to promote sleep; it is effective for falling asleep but carries a recognised risk of dependence, tolerance, and complex sleep behaviours such as sleepwalking. Belsomra works by a different mechanism, blocking orexin, a brain chemical that promotes wakefulness, so rather than sedating the brain it reduces the drive to stay awake; it helps with both falling and staying asleep and is thought to have a lower potential for dependence, though it is still a controlled substance and can cause next-day drowsiness. Neither is simply better; the choice depends on the person, the type of insomnia, and individual risk factors, and is made with a doctor. Both are intended for short-term or carefully managed use, both can cause next-day grogginess, and both should be taken exactly as prescribed and not combined with alcohol. Because Ambien in particular carries a real risk of dependence and addiction, if use of either sleep medication has become hard to control, that is a signal to seek help.
Belsomra vs Ambien: what is the difference?
Belsomra (the brand name for suvorexant) and Ambien (the brand name for zolpidem) are both prescription medications approved to treat insomnia, but the key difference between them is how they work. Ambien is a sedative-hypnotic, specifically one of the so-called Z-drugs, which work in a similar way to benzodiazepines by enhancing the effect of GABA, a calming chemical in the brain, to promote sleep. Belsomra works by an entirely different mechanism: it blocks orexin, a brain chemical that promotes wakefulness, so instead of sedating the brain it reduces the signal that keeps a person awake. This fundamental difference in mechanism shapes how the two drugs feel, what they are best at, and, importantly, their differing risks of dependence.
This article compares Belsomra and Ambien, explaining the different ways they work, how they compare in effectiveness and side effects, and the differences in their dependence and addiction risk. The central points are that neither medication is simply better than the other, that the right choice depends on the individual, the type of insomnia, and personal risk factors, and that the decision should be made with a doctor. A particularly important difference is risk: Ambien has a well-recognised potential for tolerance, dependence, and certain unusual side effects, while Belsomra is thought to carry a lower potential for dependence, though it is still a controlled substance with its own side effects. Both are intended for short-term or carefully managed use, and understanding how they differ helps a person and their doctor choose appropriately and use either safely.
How they work: different mechanisms
Ambien (zolpidem) works by enhancing the activity of GABA, the main calming neurotransmitter in the brain, at the same kind of receptors that benzodiazepines act on. By boosting this calming signal, Ambien sedates the brain and promotes sleep, which makes it effective particularly for helping people fall asleep. Because it works through this sedative mechanism similar to benzodiazepines, it shares some of their characteristics, including effectiveness for sleep onset but also a recognised potential for tolerance and dependence and the possibility of complex sleep behaviours. Ambien is generally fast-acting and intended for short-term use.
Belsomra (suvorexant) takes a completely different approach. Rather than sedating the brain, it blocks orexin, a neurotransmitter that promotes wakefulness and keeps us alert. Orexin is part of the system that maintains being awake, so by reducing orexin activity, Belsomra lowers the drive to stay awake, allowing sleep to occur more naturally. This mechanism is sometimes described as turning down wakefulness rather than forcing sedation. Because of how it works, Belsomra can help both with falling asleep and with staying asleep through the night, and it is thought to be less likely to cause the kind of dependence associated with GABA-acting drugs like Ambien, though it is still a controlled substance. This difference in mechanism, GABA-enhancing sedation for Ambien versus orexin-blocking for Belsomra, is the heart of the distinction between the two medications and explains many of the differences in their effects and risks.
| Feature | Ambien (zolpidem) | Belsomra (suvorexant) |
|---|---|---|
| Drug type | Sedative-hypnotic (Z-drug) | Orexin receptor antagonist |
| Mechanism | Enhances GABA (sedates brain) | Blocks orexin (reduces wakefulness) |
| Best for | Falling asleep | Falling and staying asleep |
| Dependence risk | Recognised, higher | Thought to be lower (still controlled) |
| Notable side effects | Complex sleep behaviours, next-day grogginess | Next-day drowsiness, vivid dreams |
| Use | Short-term | Short-term or as advised |
Effectiveness and side effects
Both Belsomra and Ambien are effective treatments for insomnia, but their strengths differ slightly because of how they work. Ambien is particularly effective at helping people fall asleep quickly, which makes it useful for sleep-onset insomnia, though standard forms may be less helpful for staying asleep through the night (an extended-release form exists for this). Belsomra, by reducing wakefulness, can help with both falling asleep and staying asleep, which can make it useful for people who wake during the night. Individual response varies, and some people find one works better for them than the other, which is part of why the choice is individualised.
Both medications can cause side effects, most notably next-day drowsiness or grogginess, which can impair driving and daily functioning, so caution is needed, especially when starting. Ambien is well known for causing complex sleep behaviours in some people, such as sleepwalking, sleep-eating, or even sleep-driving, with no memory of the event, which can be dangerous and is a recognised warning associated with the drug; it can also cause confusion and, in some people, problems with memory. Belsomra can cause next-day drowsiness, unusual or vivid dreams, and, less commonly, sleep paralysis or a sense of weakness; complex sleep behaviours have also been reported with it, though it is generally considered to have a somewhat different side-effect profile. Both should be taken exactly as prescribed, only when a full night’s sleep is possible, and never combined with alcohol or other sedatives, which increases the risks. Side effects should be discussed with the prescribing doctor.
Dependence and addiction risk
A key difference between the two, and a major reason the distinction matters, is their risk of dependence and addiction. Ambien, because it works like benzodiazepines by enhancing GABA, carries a well-recognised potential for tolerance (needing more for the same effect), dependence (so that stopping after regular use can cause withdrawal and rebound insomnia), and misuse and addiction in some people, particularly with longer-term or higher-dose use. This is why Ambien is intended for short-term use and why stopping after regular use should be done carefully, sometimes with a taper, under medical guidance. Some people do misuse zolpidem for its sedative or, paradoxically, for unusual disinhibited effects, and dependence can develop.
Belsomra, by contrast, is thought to carry a lower potential for dependence and abuse than Ambien, because it does not act through the GABA system; its orexin-blocking mechanism is not associated with the same kind of reinforcing sedative effect. However, lower risk does not mean no risk: Belsomra is still a controlled substance, recognised as having some potential for misuse and dependence, and it should still be used as prescribed. For both medications, the safest approach is short-term or carefully managed use at the lowest effective dose, alongside attention to sleep habits and any underlying causes of insomnia, since medication is generally not a long-term solution on its own. Because Ambien in particular carries a real risk of dependence and addiction, anyone who finds their use of either sleep medication has become hard to control, who is taking more than prescribed, or who cannot sleep without it should talk to their doctor, and help is available.
Summary
Belsomra (suvorexant) and Ambien (zolpidem) are both prescription medications approved to treat insomnia, but they work in completely different ways. Ambien is a sedative-hypnotic (a Z-drug) that works like benzodiazepines, enhancing the calming brain chemical GABA to promote sleep; it is effective for falling asleep but carries a recognised risk of dependence, tolerance, and complex sleep behaviours such as sleepwalking. Belsomra works by blocking orexin, a brain chemical that promotes wakefulness, so rather than sedating the brain it reduces the drive to stay awake; it helps with both falling and staying asleep and is thought to have a lower potential for dependence, though it is still a controlled substance and can cause next-day drowsiness. Neither is simply better; the choice depends on the person, the type of insomnia, and individual risk factors, and is made with a doctor. Both are intended for short-term or carefully managed use, both can cause next-day grogginess, and both should be taken exactly as prescribed and not combined with alcohol. Because Ambien in particular carries a real risk of dependence and addiction, if use of either sleep medication has become hard to control, that is a signal to seek help.
As Dr. Ponlawat Pitsuwan, addiction medicine specialist at Phuket Island Rehab, puts it, “The most useful thing to understand about Belsomra versus Ambien is that they work in opposite directions, in a sense: Ambien sedates the brain through the GABA system, much like a benzodiazepine, while Belsomra simply turns down the wakefulness signal by blocking orexin. That difference is why I pay close attention to dependence. Ambien has a real potential for tolerance and dependence, and I have seen people who cannot sleep without it. Belsomra appears to carry less of that risk, though it is not zero. Whichever we use, I treat it as short-term, lowest dose, and we always look at the sleep itself, not just the pill.”
Frequently asked questions
What is the main difference between Belsomra and Ambien?
The main difference is how they work. Ambien (zolpidem) is a sedative-hypnotic Z-drug that works like benzodiazepines, by enhancing GABA, a calming brain chemical, to sedate the brain and promote sleep. Belsomra (suvorexant) works in a completely different way, by blocking orexin, a brain chemical that promotes wakefulness, so it reduces the drive to stay awake rather than sedating the brain. This difference in mechanism leads to other differences: Ambien is especially good for falling asleep but carries a recognised risk of dependence, tolerance, and complex sleep behaviours; Belsomra helps with both falling and staying asleep and is thought to have a lower dependence potential, though it is still a controlled substance. Neither is simply better, and the choice depends on the person and the type of insomnia, decided with a doctor. Both are for short-term or carefully managed use.
Which is safer, Belsomra or Ambien?
In terms of dependence and certain side effects, Belsomra is generally thought to carry a somewhat lower risk than Ambien, mainly because it does not act through the GABA system associated with tolerance and dependence. Ambien has a well-recognised potential for tolerance, dependence, and misuse, and is particularly associated with complex sleep behaviours such as sleepwalking. Belsomra is thought to have a lower dependence potential, though it is still a controlled substance and has its own side effects, such as next-day drowsiness and vivid dreams. However, safer does not mean risk-free, and both medications require care: both can cause next-day grogginess that impairs driving, both should be taken only as prescribed and not with alcohol, and both are intended for short-term use. Which is safer for a particular person also depends on their individual risk factors and health, so the choice should be made with a doctor rather than assumed from general comparisons.
Is Belsomra addictive like Ambien?
Belsomra is thought to be less addictive than Ambien, but it is not entirely without risk. Ambien works like benzodiazepines by enhancing GABA, and this mechanism carries a recognised potential for tolerance, dependence, and misuse, especially with longer-term or higher-dose use; some people come to feel they cannot sleep without it. Belsomra works by blocking orexin, a mechanism not associated with the same reinforcing sedative effect, so it is believed to have a lower potential for dependence and abuse. However, Belsomra is still a controlled substance, recognised as having some potential for misuse and dependence, so it should still be used as prescribed and for short-term or carefully managed use. The practical message is that while Belsomra likely carries less dependence risk than Ambien, neither should be relied on long-term without medical guidance, and any sense that you cannot sleep without a sleep medication is a reason to talk to your doctor.
Can you switch from Ambien to Belsomra?
Switching from Ambien to Belsomra is sometimes done, but it should be done under a doctor’s guidance rather than on your own. A doctor might consider switching a person from Ambien to Belsomra for various reasons, for example if Ambien is causing problematic side effects such as complex sleep behaviours, if there are concerns about dependence, or if Ambien is not adequately helping with staying asleep. Because the two drugs work differently, the switch involves stopping one and starting the other appropriately; if a person has been taking Ambien regularly, it may need to be reduced carefully to avoid rebound insomnia or withdrawal. Any change between sleep medications should be planned with the prescribing doctor, who can manage the transition safely and address the underlying insomnia. If your current sleep medication is not working well or is causing concern, the right step is to discuss it with your doctor rather than adjusting or switching medications yourself.
What are the side effects of Belsomra and Ambien?
Both can cause next-day drowsiness or grogginess, which can impair driving and daily functioning. Ambien is particularly associated with complex sleep behaviours such as sleepwalking, sleep-eating, or sleep-driving with no memory of the event, which can be dangerous, and it can also cause confusion and memory problems in some people. Belsomra can cause next-day drowsiness, unusual or vivid dreams, and less commonly sleep paralysis or a temporary sense of weakness on waking; complex sleep behaviours have also been reported with it. Both can cause dizziness and, rarely, more serious effects. The risks of both are increased by alcohol and other sedatives and by taking them when a full night’s sleep is not possible. Side effects should be discussed with the prescribing doctor, and any complex sleep behaviour, such as doing things while not fully awake, should be reported promptly, as it is a reason to stop the medication and reassess.
Are sleep medications a long-term solution for insomnia?
Generally no. Sleep medications such as Belsomra and Ambien are intended for short-term or carefully managed use rather than as a long-term solution, because of the risks of tolerance, dependence (especially with Ambien), side effects, and the fact that they do not address the underlying causes of insomnia. For long-term insomnia, approaches that tackle the root of the problem tend to be more effective and sustainable, particularly cognitive behavioural therapy for insomnia (CBT-I), which is recommended as a first-line treatment, along with attention to sleep habits, routines, stress, and any underlying medical or mental health conditions. Medication can have a useful short-term role, but relying on it nightly over the long term is not ideal and can lead to dependence. If you find you cannot sleep without medication or have been using it long-term, talk to your doctor about addressing the underlying insomnia and, where needed, safely reducing the medication.
Sources
National Library of Medicine (MedlinePlus). Suvorexant; Zolpidem. https://medlineplus.gov/druginfo/meds/a615022.html
Food and Drug Administration (FDA). Belsomra and Ambien Prescribing Information; Safety Communications. https://www.fda.gov/drugs
National Institute on Drug Abuse (NIDA). Prescription Sedatives. https://nida.nih.gov/research-topics/prescription-cns-depressants
American Academy of Sleep Medicine. Clinical Practice Guideline for Chronic Insomnia. https://aasm.org/
Substance Abuse and Mental Health Services Administration (SAMHSA). Prescription Drug Misuse. https://www.samhsa.gov/
National Institute for Health and Care Excellence (NICE). Insomnia guidance. https://www.nice.org.uk/
Belsomra vs Ambien — key entities and related terms
belsomra vs ambien, Belsomra, suvorexant, Ambien, zolpidem, sleep medication, insomnia, sedative-hypnotic, Z-drug, orexin, orexin receptor antagonist, GABA, benzodiazepine, receptor, brain, mechanism, action, wakefulness, falling asleep, staying asleep, night, sleep onset, extended-release, approved, treat, treatment, effective, dose, next-day drowsiness, grogginess, complex sleep behaviours, sleepwalking, sleep-driving, vivid dreams, sleep paralysis, memory, confusion, side effects, alcohol, sedatives, tolerance, dependence, rebound insomnia, withdrawal, misuse, abuse, addiction, controlled substance, potential, risk, taper, short-term, CBT-I, sleep habits, doctor, medical, prescribed, patients, people, taking, use, different, activity, symptoms, problems, help, SAMHSA, NIDA, FDA, NICE, MedlinePlus, Phuket Island Rehab, Dr. Ponlawat Pitsuwan